DAN Explores Depression and Manic Depression and the Drugs Used as Treatment
By Ernest Campbell, M.D., FACS
Little research exists to characterize the relationship between mental conditions and scuba diving. Other than the obvious reasons people shouldn't dive -- i.e., they are out of touch with reality, severely depressed and suicidal or paranoid with delusions and hallucinations -- many people with everyday anxieties, fears and neuroses can dive and do so safely.
Successful divers have psychological profiles that are positively correlated to intelligence and characterized by an average or below-average level of neuroticism. These divers generally score well on studies of self-sufficiency and emotional stability, according to diving physiologist Dr. Glen Egstrom.
Some actual psychological disturbances are well known, but, as for the risks of scuba diving, documented and studied cases are few in number. These include the depressions, bipolar disorder, anxiety and phobias, panic disorders, narcolepsy and schizophrenia.
In addition to the risks caused by the condition itself, we must add the possible hazards of the effects of medications taken singly or, even more dangerously, in combination. No scientific studies show data that can confirm the relative safety or danger of taking any given medication.
In terms of danger to divers, medications usually play a secondary role to the condition for which the medication is prescribed. Plainly a powerful drug, a mood-altering medication, should be used with care by divers. Drugs that carry warnings indicating they are dangerous for use while driving or when operating hazardous equipment should also be considered risky for divers; if they're dangerous for drivers, they're risky for divers. The interaction between the physiological effects of diving and the pharmacological effects of medications is usually an educated, yet empirically unproven, assumption. Each situation requires individual evaluation, and no general rule applies to all. Another unknown is the additive effect of nitrogen narcosis on the actual effects of the medication.
Finally, divers have different chemistries and personalities; because of the effects of various gases under pressure, each diver responds differently to abnormal physiological states and changes in their environment. Diving conditions such as decompression illness, inert gas narcosis, carbon dioxide toxicity, oxygen toxicity, high-pressure nervous syndrome and deep-water blackout all can cause reactions that are similar to a psychoneurotic reaction or an abnormal condition of the brain.
Before advising for or against diving, the certifying physician must know all the possibilities and variations in each case of a diver with psychological issues.
Depressive Disorders
Depression (Unipolar Disorder) and Manic Depression Bipolar Disorder)
Overview of Depressive Illnesses and Their Symptoms
Depression and manic depression, two major types of depressive illnesses, are known as affective disorders, or mood disorders, because they primarily affect a person's mood. Different terms, respectively, for affective disorders include unipolar and bipolar disorders.
Depression is a persistent condition that can interfere with a person's ability to sleep, eat and hold a job and can last for weeks or months at a time. A depressed person almost always feels sad. It becomes difficult to feel any pleasure in life and the person can even become suicidal. Other symptoms include feelings of hopelessness and guilt, loss of interest in normal activities, reduced sex drive, changes in eating habits, insomnia, restlessness and poor concentration.
In this section, we will predominately discuss major depressive disorder and manic depression, encompassing symptoms of depression and mania, with wide mood swings, from deep sadness to the other extreme of elation, often losing touch with reality.
Each year, a large number of American adults -- the figure varying from 10 million to 19 million according to the source -- suffer from an affective disorder.
If you've never experienced depression, chances are that at some point in your life, you will. Women are twice as likely as men to experience major depression, while manic depression occurs equally among men and women. The highest percentage of these illnesses occurs between the ages of 25 and 44, according to Hopkins Technology, LLC.
Where do these illnesses come from? Genetic, biochemical and environmental factors each can play a role in the onset and progression of such illnesses. We all can experience occasional emotional highs and lows, but depressive disorders are characterized by extremes in intensity and duration. Hopkins records also indicate that people hospitalized for depression have a suicide rate as high as 15 percent.
Of all psychiatric illnesses, affective disorders respond well to treatment. If given proper care, approximately 80 percent of patients with major depression demonstrate significant improvement and lead productive lives, according to the National Institute of Mental Health (NIMH). Although the rate of successful treatment success is not as high for manic depression, a substantial number experience a return to a higher quality of life.
The Cause of Affective Disorders
Research shows that some people may have a genetic predisposition to affective disorders. If someone in your family has had such an illness, this does not necessarily mean that you will develop it. On the other hand, if you do develop an affective disorder, it does not explain conclusively why you did. Having a family member with an affective disorder does increase your chances of experiencing depression of an endogenous, or biological, origin. Commonly called clinical depression, these disorders are distinguished from short-term states of depressed mood or unhappiness. Even if you don't have a genetic predisposition, your body chemistry can trigger the onset of a depressive disorder due to the presence of another illness, altered health habits, substance abuse or hormonal fluctuations.
Distressing life events can also trigger reactive depression. Losses and repeated disillusionment, from death to disappointment in love, can cause people to feel depressed, especially if they have not developed effective coping skills. If these symptoms persist for more than two weeks, with a leveling or increasing in intensity, this reactive depression may actually have evolved into a clinical depression.
Whatever the cause, the presence of depressive or manic-depressive illness indicates an imbalance in the brain chemicals known as neurotransmitters. This means the brain's electrical mood-regulating system is not operating as it should.
An episode of depression can usually be treated successfully with psychotherapy or antidepressant medication, or a combination of the two. The choice depends on the exact nature of the illness. With treatment, up to 80 percent of people with depression show improvement, usually in a matter of weeks, according to the NIMH.
Underlying their mood swings, most people with depression have anger and anxiety. Certifying or allowing a diver with depression to continue to dive carries with it significant dangers to the diver, his buddy and others on the dive excursion who may be attempting a rescue. It is possible that some scuba fatalities were actually suicides, apparently decided on the spur of the moment, but this is very difficult to prove.
Clearly, any condition that clouds a diver's ability to make decisions underwater poses dangers; diving under such conditions should not be allowed. In addition, we rarely have knowledge about drug changes resulting from the physiological effects of diving. Since such mood-altering drugs used to treat depression are clearly potent, people should use caution when they dive, paying particular attention to the warnings about use.
Discontinuing the drug to dive, even for a short period of time, may be unwise. The effects of a hiatus can play havoc with your body chemistry and affect your sense of well-being.
Depression
If symptoms of depression persist for longer than two weeks (see sidebar for a listing of the most commons signs), divers experiencing four or more of the symptoms of either depression, manic-depression or symptoms of both should seek professional help and stop diving until the problem is managed.
Divemasters and instructors should learn to recognize any changes in their divers' appearances, reactions and personalities and be quick to note any of the above signs and symptoms. Medical professionals should be alert to the dangers of diving for individuals who have these conditions or who take medications that might alter consciousness or affect a diver's ability to make decisions underwater.
Advice About Diving
Should a person with depression be certified as "fit to dive"? The merits of each case should be considered, including the type of drugs required, the response to medication and the length of time free of depressive or manic incidents. Most, particularly those divers who have responded well to medications over a long term, probably could receive clearance to dive.
We should also consider the following factors: decision-making ability, responsibility for other divers, and drug-induced side effects that could limit a diver's ability to gear up and move in the water.
In all cases, prospective divers should be mindful of the safety of buddies, dive instructors, divemasters and other individuals affected by a diving incident. Prospective divers should provide full disclosure of their conditions and medications to the dive instructor and certifying agency.
MEDICATIONS
For depression and bipolar disorders
(NOTE: In all cases, the generic name is first, followed by various brand names.)
Buprenorphine/Buprenex
Buprenorphine has been used to treat depression that has not responded to usual medication regimens used to start treatment, such as Prozac and Zoloft.
Possible side effects that may be adverse to diving:
Buproprion/Wellbutrin or Zyban
Buproprion is used to treat depression, attention deficit disorder, manic-depression and smoking cessation.
Possible side effect that may be adverse to diving:
Buspirone/Buspar
Buspirone, used to treat anxiety or depressive symptoms, aggressiveness, irritability or agitation. This medication may augment the effectiveness of an antidepressant by reducing anxiety, aggression and obsessive-compulsive symptoms.
Possible side effects that may be adverse to diving:
Carbamazepine/Tegretol
This medication can prevent or reduce the severity of mood swings; it is also helpful in preventing the recurrence of depression.
Possible side effects that may be adverse to diving:
Lamotrigine/Lamictal
Lamotrigine belongs to a group of medications called anticonvulsants, which are used to control seizure disorders. In psychiatry, lamotrigine may also be used to stabilize mood, especially in manic-depressive disorders.
Possible side effects that may be adverse to diving:
Lithium/Lithonate, Eskalith, Lithobid or Lithane
This medication has several uses. When taken regularly, lithium helps prevent or reduce the severity of mood swings. Lithium can also be used to augment the effectiveness of an antidepressant.
Possible side effects that may be adverse to diving:
NOTE: Too much lithium can cause toxicity, with nausea and vomiting, diarrhea, tremor, dizziness, sleepiness, slurred speech and balance problems.
Monoamine-Oxidase Inhibitors (MAOIs):
Phenelzine/Nardil and Tranylcypromine/Parnate
MAOIs are used to treat depression and anxiety disorders. This medication is usually well tolerated.
Possible side effects that may be adverse to diving:
Methylphenidate/Ritalin
Methylphenidate is used to treat attention deficit disorder and to augment the effects of antidepressants as a mood elevator.
Possible side effects that may be adverse to diving:
Mirtazapine/Remeron
Mirtazapine is used to treat depressive and anxiety symptoms.
Possible side effects that may be adverse to diving:
Venlafaxine/Effexor
Venlafaxine is used to treat depressive symptoms and attention deficit hyperactivity disorder.
Possible side effects that may be adverse to diving:
S-Adenosyl-L-Methionine (SAMe)
SAMe has been shown to alleviate depression, reduce symptoms of fibromyalgia, slow progress of osteoarthritis, improve memory, reduce alcohol-induced liver damage, and possibly reduce symptoms of attention deficit hyperactivity disorder.
Possible side effects that may be adverse to diving:
Sertraline/Zoloft
Sertraline is used to treat depression, anxiety and obsessive
Possible side effects that may be adverse to diving:
St. John's Wort
While the herb St. John's Wort is used to treat mild to moderate depression and possibly anxiety, it is not recommended for treatment of severe depression, including depression with suicidal thoughts, psychotic features (hallucinations, confused thoughts), or melancholia (weight loss, early morning awakening, very low energy).
Possible side effects that may be adverse to diving:
Tricylic Antidepressants -- Tofranil, Elavil, Endep, Norpramine, Pertofrane, Pamelor, Aventyl, Surmontil, Vivactil, Adapin, Sinequan, Anafranil
In fixed-dose combination with other agents (e.g., Etrafon, Triavil, Limbitrol). Tricyclic antidepressants are used to treat depression, anxiety and chronic pain.
Possible side effects that may be adverse to diving:
Topiramate/Topamax
Topiramate belongs to a group of medications called anticonvulsants, used to control seizure disorders. In psychiatry, topiramate may also be used to stabilize mood, especially in manic-depression.
Possible side effects that may be adverse to diving:
Trazodone/Desyrel
Trazodone is used to treat depression, some sleep problems and agitation.
Possible side effects that may be adverse to diving:
Valproic Acid/Depakote
Valproic acid belongs to a group of medications called anticonvulsants, used to control seizure disorders, but in psychiatry valproic acid may also be used to stabilize mood, especially in manic-depressives.
Possible side effects that may be adverse to diving:
Nefazodone/Serzone
Nefazodone is used to treat depression and anxiety symptoms.
Possible side effects that may be adverse to diving:
Paroxetine/Paxil
Paroxetine is used to treat depression, anxiety and obsessive-compulsive disorder.
Possible side effects that may be adverse to diving:
For more information on depression and medications, consult with your doctor, with the DAN medical department or with Dr. Campbell.
REFERENCES
National Institute of Mental Health, Information Resources and Inquiries Branch, 6001 Executive Boulevard, Room 8184, MSC 9663, Bethesda, MD 20892-9663, Telephone: +1-301-443-4513, FAX: +1-301-443-4279, Depression brochures: +1-800-421-4211, TTY: +1-301-443-8431, FAX4U: +1-301-443-5158, Email: nimhinfo@nih.gov, Website: http://www.nimh.nih.gov
National Alliance for the Mentally Ill, Colonial Place Three, 2107 Wilson Blvd., Suite 300, Arlington, VA 22201-3042, +1-703-524-7600; 1-800-950-NAMI, Website: http://www.nami.org
National Depressive and Manic Depressive Association, 730 N. Franklin, Suite 501, Chicago, IL 60601, +1-312- 642-0049; +1-800-826-3632, Website: http://www.ndmda.org
National Foundation for Depressive Illness, Inc., P.O. Box 2257, New York, NY 10016, +1-212-268-4260; 1-800-239-1265, Website: http://www.depression.org
National Mental Health Association, 1021 Prince Street, Alexandria, VA 22314-2971, +1-703 684-7722; +1-800-969-6642, FAX: +1-703-684-5968, TTY: +1-800-433-5959, Website: http://www.nmha.org
Robins LN and Regier DA (Eds) (1990). Psychiatric Disorders in America, The Epidemiologic Catchment Area Study, New York: The Free Press.
Glen Egstrom, PhD, Medical Seminars, 1994. Stress and Performance in Diving by Arthur J Bachrach, Glen H Egstrom, 1987.
Frank E, Karp JF, and Rush AJ (1993). Efficacy of treatments for major depression. Psychopharmacology Bulletin, 29:457-75.
Lebowitz BD, Pearson JL, Schneider LS, Reynolds CF, Alexopoulos GS, Bruce MI, Conwell Y, Katz IR, Meyers BS, Morrison MF, Mossey J, Niederehe G, and Parmelee P (1997). Diagnosis and treatment of depression in late life: Consensus statement update. Journal of the American Medical Association, 278:1186-90.
Robins LN and Regier DA (Eds) (1990). Psychiatric Disorders in America, The Epidemiologic Catchment Area Study, New York: The Free Press.
Vitiello B and Jensen P (1997). Medication development and testing in children and adolescents. Archives of General Psychiatry, 54:871-6.
http://www.hoptechno.com/effect.htm
National Depression and Manic-Depression Association, http://www.ndmda.org/medfacts.htm
NIMH, http://www.ndmda.org/medfacts.htm
http://www.biopsychiatry.com/sameart.html
U.S. Department of Education, http://www.ldonline.org/ld_indepth/add_adhd/add_doe_facts.html#anchor550162
From the September/October 2000 issue of Alert Diver.